Search

Your search keyword '"Strawbridge, Rebecca"' showing total 9 results
Start Over Author "Strawbridge, Rebecca" Language undetermined
9 results on '"Strawbridge, Rebecca"'

1. sj-docx-1-jop-10.1177_02698811231161627 – Supplemental material for A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects

Author

Hartland, Hannah, Mahdavi, Kimia, Jelen, Luke A, Strawbridge, Rebecca, Young, Allan H, and Alexander, Laith

Subjects
FOS: Psychology, FOS: Clinical medicine, 170199 Psychology not elsewhere classified, 110319 Psychiatry (incl. Psychotherapy), 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, sj-docx-1-jop-10.1177_02698811231161627 for A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects by Hannah Hartland, Kimia Mahdavi, Luke A Jelen, Rebecca Strawbridge, Allan H Young and Laith Alexander in Journal of Psychopharmacology

Published
2023
Full Text
View/download PDF

2. sj-docx-1-jop-10.1177_02698811221104058 – Supplemental material for Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression

Author

Scott, Fraser, Hampsey, Elliot, Gnanapragasam, Sam, Carter, Ben, Marwood, Lindsey, Taylor, Rachael W, Emre, Cansu, Korotkova, Lora, Martín-Dombrowski, Jonatan, Cleare, Anthony J, Young, Allan H, and Strawbridge, Rebecca

Subjects
FOS: Psychology, FOS: Clinical medicine, 170199 Psychology not elsewhere classified, 110319 Psychiatry (incl. Psychotherapy), 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, sj-docx-1-jop-10.1177_02698811221104058 for Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression by Fraser Scott, Elliot Hampsey, Sam Gnanapragasam, Ben Carter, Lindsey Marwood, Rachael W Taylor, Cansu Emre, Lora Korotkova, Jonatan Martín-Dombrowski, Anthony J Cleare, Allan H Young and Rebecca Strawbridge in Journal of Psychopharmacology

Published
2022
Full Text
View/download PDF

3. sj-docx-1-jop-10.1177_02698811221115762 – Supplemental material for The effects of reserpine on depression: A systematic review

Author

Strawbridge, Rebecca, Javed, Rahila R, Cave, Jeremy, Jauhar, Sameer, and Young, Allan H

Subjects
FOS: Psychology, FOS: Clinical medicine, 170199 Psychology not elsewhere classified, 110319 Psychiatry (incl. Psychotherapy), 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, sj-docx-1-jop-10.1177_02698811221115762 for The effects of reserpine on depression: A systematic review by Rebecca Strawbridge, Rahila R Javed, Jeremy Cave, Sameer Jauhar and Allan H Young in Journal of Psychopharmacology

Published
2022
Full Text
View/download PDF

5. Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis

Author

Carter, Ben, Strawbridge, Rebecca, Husain, Muhammad Ishrat, Jones, Brett D. M., Short, Roxanna, Cleare, Anthony J., Tsapekos, Dimosthenis, Patrick, Fiona, Marwood, Lindsey, Taylor, Rachael W., Mantingh, Tim, Angel, Valeria De, Nikolova, Viktoriya L., Carvalho, Andre F., and Young, Allan H.

Abstract

Most interventions for treatment-resistant depression (TRD) are added as augmenters. We aimed to determine the relative effectiveness of augmentation treatments for TRD. This systematic review and network meta-analysis (NMA) sought all randomized trials of pharmacological and psychological augmentation interventions for adults meeting the most common clinical criteria for TRD. The NMA compared the intervention effectiveness of depressive symptoms for TRD augmentation. Of 36 included trials, 27 were suitable for inclusion in NMA, and no psychological trials could be included in the absence of a common comparator. Antipsychotics (13 trials), mood stabilizers (three trials), NMDA-targeting medications (five trials), and other mechanisms (3 trials) were compared against placebo. NMDA treatments were markedly superior to placebo (ES = 0.91, 95% CI 0.67 to 1.16) and head-to-head NMA suggested that NMDA therapies had the highest chance of being an effective treatment option compared to other pharmacological classes. This study provides the most comprehensive evidence of augmenters’ effectiveness for TRD, and our GRADE recommendations can be used to guide guidelines to optimize treatment choices. Although conclusions are limited by paucity of, and heterogeneity between, trials as well as inconsistent reports of treatment safety. This work supports the use of NMDA-targeting medications such as ketamine.

Published
2020
Full Text
View/download PDF

6. Taylor_et_al._Supplementary_material – Supplemental material for Predictors of response to augmentation treatment in patients with treatment-resistant depression: A systematic review

Author

Taylor, Rachael W, Marwood, Lindsey, Greer, Ben, Strawbridge, Rebecca, and Cleare, Anthony J

Subjects
FOS: Psychology, FOS: Clinical medicine, 170199 Psychology not elsewhere classified, 110319 Psychiatry (incl. Psychotherapy), 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, Taylor_et_al._Supplementary_material for Predictors of response to augmentation treatment in patients with treatment-resistant depression: A systematic review by Rachael W Taylor, Lindsey Marwood, Ben Greer, Rebecca Strawbridge and Anthony J Cleare in Journal of Psychopharmacology

Published
2019
Full Text
View/download PDF

7. MOESM1 of Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative

Author

Scott, Jan, Hidalgo-Mazzei, Diego, Strawbridge, Rebecca, Young, Allan, Resche-Rigon, Matthieu, Etain, Bruno, Andreassen, Ole, Bauer, Michael, Bennabi, Djamila, Blamire, Andrew, Boumezbeur, Fawzi, Brambilla, Paolo, Cattane, Nadia, Cattaneo, Annamaria, Chupin, Marie, Coello, Klara, Cointepas, Yann, Colom, Francesc, Cousins, David, Dubertret, Caroline, Duchesnay, Edouard, Ferro, Adele, Garcia-Estela, Aitana, Goikolea, Jose, Grigis, Antoine, Haffen, Emmanuel, HøEgh, Margrethe, Jakobsen, Petter, Janos Kalman, Kessing, Lars, Klohn-Saghatolislam, Farah, Lagerberg, Trine, LandÊn, Mikael, Lewitzka, Ute, Lutticke, Ashley, Mazer, Nicolas, Mazzelli, Monica, Mora, Cristina, Muller, Thorsten, Estanislao Mur-Mila, Oedegaard, Ketil, Oltedal, Leif, Pülsson, Erik, Orfanos, Dimitri Papadopoulos, Papiol, Sergi, Perez-Sola, Victor, Reif, Andreas, Ritter, Philipp, Rossi, Roberto, Schulze, Thomas, Senner, Fanny, Smith, Fiona, Squarcina, Letizia, Steen, Nils, Thelwall, Pete, Varo, Cristina, Vieta, Eduard, Vinberg, Wessa, Michele, Westlye, Lars, and Bellivier, Frank

Abstract

Additional file 1: Appendix S1. Country and location of centres involved in R-LiNK.

Published
2019
Full Text
View/download PDF

8. MOESM2 of Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative

Author

Scott, Jan, Hidalgo-Mazzei, Diego, Strawbridge, Rebecca, Young, Allan, Resche-Rigon, Matthieu, Etain, Bruno, Andreassen, Ole, Bauer, Michael, Bennabi, Djamila, Blamire, Andrew, Boumezbeur, Fawzi, Brambilla, Paolo, Cattane, Nadia, Cattaneo, Annamaria, Chupin, Marie, Coello, Klara, Cointepas, Yann, Colom, Francesc, Cousins, David, Dubertret, Caroline, Duchesnay, Edouard, Ferro, Adele, Garcia-Estela, Aitana, Goikolea, Jose, Grigis, Antoine, Haffen, Emmanuel, HøEgh, Margrethe, Jakobsen, Petter, Janos Kalman, Kessing, Lars, Klohn-Saghatolislam, Farah, Lagerberg, Trine, LandÊn, Mikael, Lewitzka, Ute, Lutticke, Ashley, Mazer, Nicolas, Mazzelli, Monica, Mora, Cristina, Muller, Thorsten, Estanislao Mur-Mila, Oedegaard, Ketil, Oltedal, Leif, Pülsson, Erik, Orfanos, Dimitri Papadopoulos, Papiol, Sergi, Perez-Sola, Victor, Reif, Andreas, Ritter, Philipp, Rossi, Roberto, Schulze, Thomas, Senner, Fanny, Smith, Fiona, Squarcina, Letizia, Steen, Nils, Thelwall, Pete, Varo, Cristina, Vieta, Eduard, Vinberg, Wessa, Michele, Westlye, Lars, and Bellivier, Frank

Subjects
3. Good health
Abstract

Additional file 2: Appendix S2. Proposed list of instruments used for baseline clinical assessments and longitudinal monitoring of symptoms, medication adherence and lithium response.

9. MOESM2 of Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative

Author

Scott, Jan, Hidalgo-Mazzei, Diego, Strawbridge, Rebecca, Young, Allan, Resche-Rigon, Matthieu, Etain, Bruno, Andreassen, Ole, Bauer, Michael, Bennabi, Djamila, Blamire, Andrew, Boumezbeur, Fawzi, Brambilla, Paolo, Cattane, Nadia, Cattaneo, Annamaria, Chupin, Marie, Coello, Klara, Cointepas, Yann, Colom, Francesc, Cousins, David, Dubertret, Caroline, Duchesnay, Edouard, Ferro, Adele, Garcia-Estela, Aitana, Goikolea, Jose, Grigis, Antoine, Haffen, Emmanuel, HøEgh, Margrethe, Jakobsen, Petter, Janos Kalman, Kessing, Lars, Klohn-Saghatolislam, Farah, Lagerberg, Trine, LandÊn, Mikael, Lewitzka, Ute, Lutticke, Ashley, Mazer, Nicolas, Mazzelli, Monica, Mora, Cristina, Muller, Thorsten, Estanislao Mur-Mila, Oedegaard, Ketil, Oltedal, Leif, Pülsson, Erik, Orfanos, Dimitri Papadopoulos, Papiol, Sergi, Perez-Sola, Victor, Reif, Andreas, Ritter, Philipp, Rossi, Roberto, Schulze, Thomas, Senner, Fanny, Smith, Fiona, Squarcina, Letizia, Steen, Nils, Thelwall, Pete, Varo, Cristina, Vieta, Eduard, Vinberg, Wessa, Michele, Westlye, Lars, and Bellivier, Frank

Subjects
3. Good health
Abstract

Additional file 2: Appendix S2. Proposed list of instruments used for baseline clinical assessments and longitudinal monitoring of symptoms, medication adherence and lithium response.

Catalog

Books, media, physical & digital resources
See catalog results